Table 1.

Patients and Treatment Characteristics.

Characteristics		HF-SIB	CF	P
		104	81
Age (years)	≤ 50	80	52	.127
	> 50	24	29
Stage	0-I	77	54	.274
	II	27	27
Menopausal	Premenopausal	49	46	.178
	Postmenopausal	30	14
	Perimenopausal	25	21
Tumor grade	I	13	5	.477
	II	42	38
	III	33	24
	Unknown	16	14
Hormone Receptor	ER +  and/or PR +	83	60	.108
	ER− and PR−	19	14
	Unknown	2	7
Her-2	+	16	12	.915
	−	88	69
Laterality	Left	50	46	.239
	Right	54	35
Quadrant	Upper outer	53	42	.167
	Lower outer	16	20
	Upper inner	25	12
	Lower inner	8	3
	Central	2	4
Operation method	BCS + ALND	35	33	.29
	BCS + SLNB	69	47
Chemotherapy	Neoadjuvant	1	4	.181
	Adjuvant	69	56
	No	34	21
Endocrine therapy	Yes	80	61	.798
	No	24	20
Position	Prone	78	62	.808
	Supine	26	19
Breast volume	150-500 cc	47	36	.886
	501-800 cc	38	32
	801-1100 cc	19	13

Abbreviation: ER, estrogen receptor; HER-2, human epidermal growth factor receptor 2; PR, progesterone receptor.